Finzati - Logo
NXTS logo

N2OFF, Inc.

NXTS • Biotechnology
$0.62
▼ -0.03 (-3.92%)
Current price
EarningsLatest report: Mar 31, 2026
HIGHER-RISK PROFILECautionConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$377,003.54
Growth
-100.0%
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.06Healthy liquidity · 4.19Negative growth trendWeak profitability
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: May 14, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:36 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$0.62
Change-3.92%
Shares Out612.72K
Market Cap$377.00K
Enterprise Value$-5.39M
Beta1.78
P/E-0.04
P/S-5.71
P/B0.03
P/FCF-0.09
EV/Sales81.73
EV/EBITDA0.51

Investment DNA

How strong this company looks for long-term investors

42
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
95/100
Why this score▼
Manageable debt level · 0.06Healthy liquidity · 4.19Negative growth trendWeak profitability
Analyst view
No analyst data available now.

Company Overview

IPO: 2/26/2026
Industry: Biotechnology
P/B i: 0.03
Debt / Equity i: 0.06
Operating Margin: 0.00%
Net Margin: 0.00%
ROE i: -
ROIC: -

Financial Health

Score15 / 20
Debt / Equity: 0.06
Current Ratio: 4.19
Quick Ratio: 4.19
Status: Good

Insider Transactions

Recent executive and insider activity

Lee Eun Young
Transaction: 01/29/2026
SELL
Change
-127
Price
$1.35
Filing
03/26/2026
Type
SELL
Lee Eun Young
Transaction: 01/22/2026
OTHER
Change
0
Price
Not reported
Filing
03/23/2026
Type
OTHER